These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 14472519)
1. [Treatment of hypertension with darenthin]. MENCZEL J; BEN-ISHAI D; LAVIE N; DAVIS E Harefuah; 1961 Sep; 61():161-4. PubMed ID: 14472519 [No Abstract] [Full Text] [Related]
2. Clinical trial of bretylium tosylate (darenthin) in hypertension. SHEE JC; THOMAS JE Cent Afr J Med; 1960 May; 6():197-8. PubMed ID: 14445704 [No Abstract] [Full Text] [Related]
3. A sympathetic blocking agent, bretylium tosylate (Darenthin), in the treatment of hypertension. CONWAY J; LAUWERS P; HOOBLER SW J Lab Clin Med; 1961 Feb; 57():199-205. PubMed ID: 13695220 [No Abstract] [Full Text] [Related]
4. [Bretylium tosylate (Darenthin). Report of an experiment on the clinical significance of bretylium tosylate in the treatment of hypertension]. ZELVELDER WG Ned Tijdschr Geneeskd; 1961 Jun; 105():1260-6. PubMed ID: 13788182 [No Abstract] [Full Text] [Related]
5. The use of bretylium tosylate (Darenthin) in hypertension. DOLLERY CT Med Clin North Am; 1961 Mar; 45():429-39. PubMed ID: 13723565 [No Abstract] [Full Text] [Related]
6. Acquired tolerance to bretylium tosylate ("darenthin") in the treatment of hypertension. HODGE RL; McPHIE JM Med J Aust; 1960 Jul; 47(2)():169-72. PubMed ID: 14402225 [No Abstract] [Full Text] [Related]
7. First experiences with a new anti-hypertensive agent 'darenthin'. MORRIS R S Afr Med J; 1960 Jan; 34():23-4. PubMed ID: 14424345 [No Abstract] [Full Text] [Related]
8. A short trial of darenthin in the treatment of hypertension in the African. FORBES JI; CARTER TD Cent Afr J Med; 1960 May; 6():191-6. PubMed ID: 13823880 [No Abstract] [Full Text] [Related]
9. The treatment of arterial hypertension with sympathetic blocking agents. O'BRIEN KP; TAYLOR VJ; IBBERTSON HK N Z Med J; 1961 Nov; 60():512-8. PubMed ID: 14480821 [No Abstract] [Full Text] [Related]
10. Darenthin: hypotensive agent of new type. BOURA AL; GREEN AF; McCOUBREY A; LAURENCE DR; MOULTON R; ROSENHEIM ML Lancet; 1959 Jul; 2(7089):17-21. PubMed ID: 13673574 [No Abstract] [Full Text] [Related]
12. [The treatment of arterial hypertension with an adrenergic-blocking agent]. KODOUNES A; SPANOLIOS G Hell Iatr; 1961 Jun; 30():684-8. PubMed ID: 14457644 [No Abstract] [Full Text] [Related]
13. Treatment of severe hypertension with bretylium tosylate. MONTUSCHI EF; PEARSON HE; WILSON LL Br Med J; 1960 Oct; 2(5207):1199-203. PubMed ID: 13772247 [No Abstract] [Full Text] [Related]
14. Bretylium tosylate in treatment of severe hypertension. SOMERS K Br Med J; 1962 Mar; 1(5282):911-3. PubMed ID: 13915098 [No Abstract] [Full Text] [Related]
15. Bretylium tosylate in the treatment of hypertension. DOLLERY CT; EMSLIE-SMITH D; McMICHAEL J Lancet; 1960 Feb; 1(7119):296-9. PubMed ID: 13817333 [No Abstract] [Full Text] [Related]
16. Sympathetic-blocking drugs in the management of hypertension. LEISHMAN AW Practitioner; 1961 Jan; 186():72-80. PubMed ID: 13760586 [No Abstract] [Full Text] [Related]
17. Sympathetic blockade in treatment of hypertension. Clinical trial of bretylium tosylate. LOWTHER CP; TURNER RW Br Med J; 1960 Oct; 2(5205):1049-53. PubMed ID: 13763868 [No Abstract] [Full Text] [Related]